• menu
    Market Place Market Place
    Sourcing SupportSourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    BLOG

    MARKET INTEL by PharmaCompass

    CONTENT by Suppliers

    News

    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.
    4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate
    |
    Data Compilation #PharmaFlow 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate

    FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

    This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s